Lv32
326 积分 2024-06-18 加入
Process Development of the Novel LpxC Inhibitor T-1228: Part 3: Optimization of the Deprotection Reaction and the Crystallization for the Final Step of API Synthesis
1天前
已完结
Rh(III)‐Catalyzed C−H Functionalization of N‐Nitrosoanilines with α‐Sulfonylcarbenes
2个月前
已完结
Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities (NDSRIs)
2个月前
已完结
Some Issues and Their Solutions in the Process Development of Ethyl 2-(4-Aminophenoxy)thiazole-5-carboxylate: A Key Intermediate of P2X3 Antagonist
2个月前
已完结
Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways
7个月前
已完结
Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy
7个月前
已完结
Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy
8个月前
已完结
Diabetic Neuropathy: Review on Molecular Mechanisms
8个月前
已完结
New Horizons in Diabetic Neuropathies: An Updated Review on their Pathology, Diagnosis, Mechanism, Screening Techniques, Pharmacological, and Future Approaches
8个月前
已完结
A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy
8个月前
已完结
皖公网安备34019202002308
